- PLN124.77m
- PLN151.42m
- PLN15.76m
Brief: Mabion FY Net Profit Up At 23.2 Mln Zlotys
Brief: Mabion Estimates Capex At About 90-100 Mln Zlotys In 2023-24 under new strategy
Brief: Mabion Signs Second Annex With Novavax On Omicron Variant
Brief: Mabion Signs Statement Of Work #10 With Novavax For Logistics Services
Brief: Mabion Terminates Agreement With PFR On Investment
Brief: Mabion Signs $15 Mln Loan Deal With EBRD
Brief: Mabion Q3 Net Loss Narrows To 5.1 Mln Zlotys
Brief: Mabion Extends Cooperation With Novavax
Brief: Mabion Terminates Subsidy Deal For Expansion Of R&D Centre
Brief: Mabion Says EBRD Credit Committee Approves Granting $15 Mln Loan To Company
Brief: Mabion Q2 Net Loss Turns To Profit Of 5.1 Mln Zlotys
Brief: Mabion Expands And Extends Deal With Novavax Till End-2026
Brief: Mabion Signs Expansion Of Production Deal With Novavax
Brief: Mabion Expands Cooperation With Novavax
Brief: Mabion Signs Statement Of Work With Novavax
Brief: Mabion Signs Extension To The Scope Of Services Under Deal With Novavax
Brief: Mabion Q1 Net Result Turns To Profit Of 7.4 Mln Zlotys
Brief: Mabion AGM To Vote on Retaining 2021 Net Profit To Cover Previous Losses
Brief: Mabion 2021 Net Result Turns To Profit Of 1.9 Mln Zlotys